Research ArticleOriginal Article
Open Access

Narcolepsy in Saudi patients before and after the 2009 H1N1 vaccination

The experience of 2 referral centers

Shaden O. Qasrawi, Ali M. Albarrak, Adel S. Alharbi, Samar Nashwan, Aljohara S. Almeneessier, Seithikurippu R. Pandi-Perumal, Muslim M. Alsaadi and Ahmed S. BaHammam
Saudi Medical Journal December 2017, 38 (12) 1196-1200; DOI: https://doi.org/10.15537/smj.2017.12.21046

References

  1. ↵
    1. Sateia MJ
    (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146:1387–1394.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Longstreth WT Jr.,
    2. Koepsell TD,
    3. Ton TG,
    4. Hendrickson AF,
    5. van Belle G
    (2007) The epidemiology of narcolepsy. Sleep 30:13–26.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Al Rajeh S,
    2. Bademosi O,
    3. Ismail H,
    4. Awada A,
    5. Dawodu A,
    6. al-Freihi H,
    7. et al.
    (1993) A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology 12:164–178.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. BaHammam AS,
    2. Alenezi AM
    (2006) Narcolepsy in Saudi Arabia. Demographic and clinical perspective of an under-recognized disorder. Saudi Med J 27:1352–1357.
    OpenUrlPubMed
  5. ↵
    1. Stowe J,
    2. Andrews N,
    3. Kosky C,
    4. Dennis G,
    5. Eriksson S,
    6. Hall A,
    7. et al.
    (2016) Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. Sleep 39:1051–1057.
    OpenUrl
  6. ↵
    1. Agency EM
    (December, 2016) Assessment report. Pandemrix 2011.
  7. ↵
    1. Bardage C,
    2. Persson I,
    3. Ortqvist A,
    4. Bergman U,
    5. Ludvigsson JF,
    6. Granath F
    (2011) Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ 343:d5956.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Nohynek H,
    2. Jokinen J,
    3. Partinen M,
    4. Vaarala O,
    5. Kirjavainen T,
    6. Sundman J,
    7. et al.
    (2012) AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PloS One 7:e33536.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Wijnans L,
    2. Lecomte C,
    3. de Vries C,
    4. Weibel D,
    5. Sammon C,
    6. Hviid A,
    7. et al.
    (2013) The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 31:1246–1254.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Miller E,
    2. Andrews N,
    3. Stellitano L,
    4. Stowe J,
    5. Winstone AM,
    6. Shneerson J,
    7. et al.
    (2013) Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 346:f794.
    OpenUrlAbstract/FREE Full Text
    1. Heier MS,
    2. Gautvik KM,
    3. Wannag E,
    4. Bronder KH,
    5. Midtlyng E,
    6. Kamaleri Y,
    7. et al.
    (2013) Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Medicine 14:867–871.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. O'Flanagan D,
    2. Barret AS,
    3. Foley M,
    4. Cotter S,
    5. Bonner C,
    6. Crowe C,
    7. et al.
    (2014) Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro Surveill 19:15–25.
    OpenUrlPubMed
  13. ↵
    1. Dauvilliers Y,
    2. Arnulf I,
    3. Lecendreux M,
    4. Monaca Charley C,
    5. Franco P,
    6. Drouot X,
    7. et al.
    (2013) Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 136(Pt 8):2486–2496.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Choe YJ,
    2. Bae GR,
    3. Lee DH
    (2012) No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study. Vaccine 30:7439–7442.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Duffy J,
    2. Weintraub E,
    3. Vellozzi C,
    4. DeStefano F
    (2014) Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 83:1823–1830.
    OpenUrlCrossRefPubMed
    1. Montplaisir J,
    2. Petit D,
    3. Quinn MJ,
    4. Ouakki M,
    5. Deceuninck G,
    6. Desautels A,
    7. et al.
    (2014) Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 9:e108489.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Harris T,
    2. Wong K,
    3. Stanford L,
    4. Fediurek J,
    5. Crowcroft N,
    6. Deeks S
    (2014) Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada?A review of post-marketing safety surveillance data. Euro Surveill 19:pii:20900.
    OpenUrl
  18. ↵
    1. Aljadhey H,
    2. Alyabsi M,
    3. Alrwisan A,
    4. Alqahtani N,
    5. Almutairi R,
    6. Al Tawil E,
    7. et al.
    (2012) The safety of H1N1 vaccine in children in Saudi Arabia: a cohort study using modern technology in a developing country. Drug Saf 35:555–561.
    OpenUrlPubMed
  19. ↵
    1. Shyoukhi N
    Glaxo for now Saudi's sole supplier of H1N1 vaccine, Available from: http://uk.reuters.com/article/flu-saudi-glaxo-idUSL715694020091107. [Update 2009; cited 2017 July 3].
  20. ↵
    1. Dauvilliers Y,
    2. Montplaisir J,
    3. Cochen V,
    4. Desautels A,
    5. Einen M,
    6. Lin L,
    7. et al.
    (2010) Post-H1N1 narcolepsy-cataplexy. Sleep 33:1428–1430.
    OpenUrlPubMedWeb of Science
  21. ↵
    1. Morrish E,
    2. King MA,
    3. Smith IE,
    4. Shneerson JM
    (2004) Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med 5:37–41.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. American Academy of Sleep Medicine
    (2005) International classification of sleep disorders (ICSD): Diagnostic and coding manual (American Academy of Sleep Medicine, Westchester (IL)), 2nd ed.
  23. ↵
    1. Kornum BR,
    2. Faraco J,
    3. Mignot E
    (2011) Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol 21:897–903.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Guimaraes LE,
    2. Baker B,
    3. Perricone C,
    4. Shoenfeld Y
    (2015) Vaccines, adjuvants and autoimmunity. Pharmacol Res 100:190–209.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section